SoMex Research & Health Organisation

News & Events

Phase I Trial Managed by SoMex Research & Health Published in ASCO 2012

A phase I study of selective cyclin dependent kinase inhibitor P1446A-05 administered on an intermittent schedule in patients with advanced refractory tumors published in ASCO 2012 (PI Dr. Naresh Somani at Bhagwan Mahaveer Cancer Hospital and Research Center, Jaipur.

Other News